Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Dent

Showing results (11-20 of 395) with videos related to

Pageof 40
Sort By:
Cancer Biology & Therapy|December 24, 2002
Ribonucleotide reductase inhibition: regulation of the radiosensitive phenotype via NF kappa B and Bcl-2Paul Dent
Cancer Biology & Therapy|September 13, 2013
Ceramide in the prostatePaul Dent
Cancer Biology & Therapy|September 13, 2013
Janus-faced Kupffer cells in tumor metastasisPaul Dent
Cancer Biology & Therapy|January 16, 2014
Crosstalk between ERK, AKT, and cell survivalPaul Dent
Cancer Biology & Therapy|March 13, 2014
Met in lung cancerPaul Dent
Cancer Biology & Therapy|September 13, 2013
Non-canonical p53 signaling to promote invasionPaul Dent
Cancer Biology & Therapy|September 13, 2013
PARP inhibitors are not all equalPaul Dent
Cancer Biology & Therapy|December 7, 2013
Multi-kinase inhibition in ovarian cancerPaul Dent
Oncoscience|February 12, 2024
A very long and winding road: developing novel therapeutics for metastatic tumorsPaul Dent
Cell Cycle (Georgetown, Tex.)|January 28, 2003
Conversion of drug-induced differentiation to apoptosis by pharmacologic cyclin-dependent kinase inhibitorsSteven Grant, Paul Dent
Pageof 40

Showing results (11-20 of 395) with videos related to

Sort By:
Pageof 40
Cancer Biology & Therapy|December 24, 2002
Ribonucleotide reductase inhibition: regulation of the radiosensitive phenotype via NF kappa B and Bcl-2Paul Dent
Cancer Biology & Therapy|September 13, 2013
Ceramide in the prostatePaul Dent
Cancer Biology & Therapy|September 13, 2013
Janus-faced Kupffer cells in tumor metastasisPaul Dent
Cancer Biology & Therapy|January 16, 2014
Crosstalk between ERK, AKT, and cell survivalPaul Dent
Cancer Biology & Therapy|March 13, 2014
Met in lung cancerPaul Dent
Cancer Biology & Therapy|September 13, 2013
Non-canonical p53 signaling to promote invasionPaul Dent
Cancer Biology & Therapy|September 13, 2013
PARP inhibitors are not all equalPaul Dent
Cancer Biology & Therapy|December 7, 2013
Multi-kinase inhibition in ovarian cancerPaul Dent
Oncoscience|February 12, 2024
A very long and winding road: developing novel therapeutics for metastatic tumorsPaul Dent
Cell Cycle (Georgetown, Tex.)|January 28, 2003
Conversion of drug-induced differentiation to apoptosis by pharmacologic cyclin-dependent kinase inhibitorsSteven Grant, Paul Dent
Pageof 40